I read with interest the study by Bailey at al. measuring the performance of the Spectrum M3 non-invasive extracorporeal saturation monitor (Spectrum Medical LLP, Gloucester, UK) [1]. Being external to the circuit, it is clear that this device could offer significant benefit in the continuous measurement of oxygen saturation, haematocrit and haemoglobin concentration (Hb), whilst avoiding additional turbulence. This would be particularly so in extracorporeal membrane oxygenation (ECMO) circuits, where bypass is maintained for several days. Whilst the agreement between the readings of the new monitor and the gold standard reference is good, with a low level of bias, the experimental conditions under which it was tested raise some questions. I am surprised that the mean (SD) Hb of the test circuit was 15.4 (0.6) g.dl−1. In practice, the circulating Hb of a cardiopulmonary bypass circuit is lower after the addition of priming fluid – in our hospital, 500 ml crystalloid and 1200 ml colloid, aiming for a Hb < 12 g.dl−1. A Hb > 15 g.dl−1 would be undesirable due to the higher viscosity, causing increased haemolysis and potentially impairing microvascular circulation [2], particularly at lower temperatures. Interestingly, the authors do not expand further upon the values of Hb in their experiment, only high, medium, low and very low, and do not present the individual results at these different values. In testing the device’s accuracy at differing temperatures, only three measurement points over a very large range of temperatures (37, 27 and 17 °C) were used. In routine clinical practice, cardiopulmonary bypass is not conducted under deep hypothermic conditions. The device’s accuracy should be tested at hypothermic limits; however, narrower intervals between measurements over the range of temperatures most commonly used clinically, above 30 °C in most cases, particularly if used for ECMO, would better prove its performance. More closely simulating the conditions encountered in clinical practice and further expanding upon the results, especially if considering the device’s use for ECMO, given that these circuits operate under considerably different conditions to those found intra-operatively, would have provided more assurance of this device’s performance.
Read full abstract